SE8600496L - Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider - Google Patents

Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider

Info

Publication number: SE8600496L
Authority: SE; Sweden
Prior art keywords: dihydroergotal; kaloids; pharmaceutical compositions; compositions containing; dihydroergotamine
Prior art date: 1985-02-05

Application number

SE8600496A

Other languages

Unknown language ( )

English (en)

Swedish (sv)

Other versions

SE8600496D0 (sv

Inventor

O Zuger

Original Assignee

Sandoz Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-02-05

Filing date

1986-02-04

Publication date

1986-08-06

1985-02-05 Priority claimed from GB858502889A external-priority patent/GB8502889D0/en

1985-07-12 Priority claimed from GB858517604A external-priority patent/GB8517604D0/en

1986-02-04 Application filed by Sandoz Ag filed Critical Sandoz Ag

1986-02-04 Publication of SE8600496D0 publication Critical patent/SE8600496D0/xx

1986-08-06 Publication of SE8600496L publication Critical patent/SE8600496L/

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
229960004704 dihydroergotamine Drugs 0.000 abstract 2
239000000463 material Substances 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
230000008961 swelling Effects 0.000 abstract 2
FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 abstract 1
206010020772 Hypertension Diseases 0.000 abstract 1
208000019695 Migraine disease Diseases 0.000 abstract 1
229930013930 alkaloid Natural products 0.000 abstract 1
150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
239000001913 cellulose Substances 0.000 abstract 1
229920002678 cellulose Polymers 0.000 abstract 1
229940074979 cetyl palmitate Drugs 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000013270 controlled release Methods 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 abstract 1
SBFXHXZNBNFPHV-PXXBSISHSA-N epicriptine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C(=O)N[C@]3(C(=O)N4[C@H](C(N5CCC[C@H]5[C@]4(O)O3)=O)[C@H](C)CC)C(C)C)=C3C2=CNC3=C1 SBFXHXZNBNFPHV-PXXBSISHSA-N 0.000 abstract 1
229960003133 ergot alkaloid Drugs 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
-1 fatty acid ester Chemical class 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 abstract 1
239000000416 hydrocolloid Substances 0.000 abstract 1
229920000609 methyl cellulose Polymers 0.000 abstract 1
239000001923 methylcellulose Substances 0.000 abstract 1
206010027599 migraine Diseases 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SE8600496A 1985-02-05 1986-02-04 Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider SE8600496L (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB858502889A GB8502889D0 (en)	1985-02-05	1985-02-05	Co-dergocrine compositions
GB858517604A GB8517604D0 (en)	1985-07-12	1985-07-12	Dihydroergotamine compositions

Publications (2)

Publication Number	Publication Date
SE8600496D0 SE8600496D0 (sv)	1986-02-04
SE8600496L true SE8600496L (sv)	1986-08-06

Family

ID=26288767

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE8600496A SE8600496L (sv)	1985-02-05	1986-02-04	Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider

Country Status (24)

Country	Link
JP (1)	JPS61183225A (fr)
KR (1)	KR920010388B1 (fr)
AU (1)	AU597570B2 (fr)
BE (1)	BE904152A (fr)
CA (1)	CA1263087A (fr)
CH (1)	CH667592A5 (fr)
CY (1)	CY1604A (fr)
DE (1)	DE3602577A1 (fr)
DK (1)	DK167138B1 (fr)
ES (1)	ES8800040A1 (fr)
FR (1)	FR2576787B1 (fr)
GB (1)	GB2170407B (fr)
GR (1)	GR860310B (fr)
HK (1)	HK57191A (fr)
HU (1)	HU195729B (fr)
IE (1)	IE59293B1 (fr)
IT (1)	IT1191255B (fr)
LU (1)	LU86289A1 (fr)
NL (1)	NL8600161A (fr)
NZ (1)	NZ215020A (fr)
PH (1)	PH23384A (fr)
PT (1)	PT81954B (fr)
SE (1)	SE8600496L (fr)
SG (1)	SG56191G (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2610827B1 (fr) *	1987-02-18	1991-09-13	Pf Medicament	Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
SI8710406B (sl) *	1987-03-11	1998-08-31	Lek	Tablete s podaljšanim delovanjem na osnovi hidroksipropilmetilceluloze z veliko molsko maso in postopek za njihovo pripravo
RU2256454C2 (ru) *	1999-12-03	2005-07-20	Полишем С.А.	Способы получения фармацевтических композиций алкалоидов спорыньи с пролонгированным действием, характеризующихся улучшенной биодоступностью, и содержащие указанные алкалоиды композиции
US7771746B2 (en)	1999-12-03	2010-08-10	Polichem Sa	Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
ATE383855T1 (de)	2000-05-12	2008-02-15	Meracol Corp Ltd	Behandlung von reizkolon-syndrom oder -krankheit
NZ504526A (en) *	2000-05-12	2003-05-30	Meracol Corp Ltd	Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate
US20030153620A1 (en)	2000-05-12	2003-08-14	Meakin Timothy David	Treating eczema and/or psoriasis
ATE381327T1 (de) *	2000-05-12	2008-01-15	Meracol Corp Ltd	Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
WO2003026640A1 (fr) *	2001-09-28	2003-04-03	Meracol Corporation Limited	Traitement d'allergies alimentaires et/ou d'intolerances alimentaires
CN111297815B (zh) *	2020-04-29	2022-04-15	宝利化（南京）制药有限公司	一种甲磺酸二氢麦角碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3147187A (en) *	1962-09-10	1964-09-01	Don Hall Lab	Sustained release pharmaceutical
CH630257A5 (en) *	1975-03-17	1982-06-15	Hoffmann La Roche	Sustained release formulation
DE3124983A1 (de) *	1981-06-25	1983-01-20	Meditest Inst Fuer Medizinisch	Arzneiformen zur oralen verabreichung
CH649300A5 (de) *	1981-08-07	1985-05-15	Sandoz Ag	Ergopeptinderivate, ihre herstellung und verwendung.
US4369172A (en) *	1981-12-18	1983-01-18	Forest Laboratories Inc.	Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
DE3303616A1 (de) *	1982-02-12	1983-08-25	Sandoz-Patent-GmbH, 7850 Lörrach	Mutterkornalkaloide, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische zubereitungen
US4421736A (en) *	1982-05-20	1983-12-20	Merrel Dow Pharmaceuticals Inc.	Sustained release diethylpropion compositions
JPS604120A (ja) *	1983-06-22	1985-01-10	Shionogi & Co Ltd	作用持続型ピナシジル製剤
GB2154874B (en) *	1984-02-29	1987-11-04	Sandoz Ltd	Bromoscriptine compositions
GB8413795D0 (en) *	1984-05-30	1984-07-04	Sandoz Ltd	Organic compounds

1986
- 1986-01-24 HU HU86361A patent/HU195729B/hu not_active IP Right Cessation
- 1986-01-24 NL NL8600161A patent/NL8600161A/nl not_active Application Discontinuation
- 1986-01-27 CH CH296/86A patent/CH667592A5/de not_active IP Right Cessation
- 1986-01-29 DE DE19863602577 patent/DE3602577A1/de not_active Ceased
- 1986-01-31 FR FR868601477A patent/FR2576787B1/fr not_active Expired - Lifetime
- 1986-02-03 KR KR1019860000698A patent/KR920010388B1/ko not_active Expired
- 1986-02-03 GR GR860310A patent/GR860310B/el unknown
- 1986-02-03 CA CA000501011A patent/CA1263087A/fr not_active Expired
- 1986-02-03 GB GB08602602A patent/GB2170407B/en not_active Expired
- 1986-02-03 BE BE1/011431A patent/BE904152A/fr not_active IP Right Cessation
- 1986-02-03 NZ NZ215020A patent/NZ215020A/xx unknown
- 1986-02-03 PT PT81954A patent/PT81954B/pt not_active IP Right Cessation
- 1986-02-03 IE IE29186A patent/IE59293B1/en not_active IP Right Cessation
- 1986-02-03 AU AU52942/86A patent/AU597570B2/en not_active Ceased
- 1986-02-03 DK DK052086A patent/DK167138B1/da not_active IP Right Cessation
- 1986-02-04 LU LU86289A patent/LU86289A1/fr unknown
- 1986-02-04 PH PH33379A patent/PH23384A/en unknown
- 1986-02-04 JP JP61023666A patent/JPS61183225A/ja active Pending
- 1986-02-04 SE SE8600496A patent/SE8600496L/ not_active Application Discontinuation
- 1986-02-04 ES ES551635A patent/ES8800040A1/es not_active Expired
- 1986-02-05 IT IT47620/86A patent/IT1191255B/it active
1991
- 1991-07-16 SG SG561/91A patent/SG56191G/en unknown
- 1991-07-25 HK HK571/91A patent/HK57191A/xx unknown
1992
- 1992-04-03 CY CY1604A patent/CY1604A/en unknown

Also Published As

Publication number	Publication date
GB2170407B (en)	1988-10-26
PH23384A (en)	1989-07-26
ES8800040A1 (es)	1987-10-16
GR860310B (en)	1986-05-27
NZ215020A (en)	1989-07-27
IE59293B1 (en)	1994-02-09
IT8647620A0 (it)	1986-02-05
JPS61183225A (ja)	1986-08-15
AU5294286A (en)	1986-08-14
ES551635A0 (es)	1987-10-16
SE8600496D0 (sv)	1986-02-04
SG56191G (en)	1991-08-23
KR860006265A (ko)	1986-09-09
DK52086A (da)	1986-08-06
DE3602577A1 (de)	1986-08-28
CA1263087A (fr)	1989-11-21
IT1191255B (it)	1988-02-24
DK167138B1 (da)	1993-09-06
IE860291L (en)	1986-08-05
BE904152A (fr)	1986-08-04
GB2170407A (en)	1986-08-06
HK57191A (en)	1991-08-02
HUT41984A (en)	1987-06-29
GB8602602D0 (en)	1986-03-12
PT81954B (pt)	1988-07-01
LU86289A1 (fr)	1986-09-02
KR920010388B1 (ko)	1992-11-27
AU597570B2 (en)	1990-06-07
CY1604A (en)	1992-04-03
DK52086D0 (da)	1986-02-03
FR2576787B1 (fr)	1990-01-12
PT81954A (en)	1986-03-01
HU195729B (en)	1988-07-28
CH667592A5 (de)	1988-10-31
FR2576787A1 (fr)	1986-08-08
NL8600161A (nl)	1986-09-01

Legal Events

Date

Code

Title

Description

1995-02-28

NAV

Patent application has lapsed

Ref document number: 8600496-7

Effective date: 19940426

Publication	Publication Date	Title
DE3379496D1 (en)	1989-05-03	Constant release rate solid oral dosage formulations of cardiovascular drugs
AU5159490A (en)	1990-09-05	Composition and method for administration of pharmaceutically active substances
EG20219A (en)	1997-11-30	Method of preparation of deiwatives indole used in preparation of pharmaceutical composition and treatment of migraine
AU3284984A (en)	1985-03-21	Pharmaceutical compositions for the transdermal application of active ingredients
PL287200A1 (en)	1991-08-12	Method of making a sticking plaster with an estrogen containing active substance incorporated into adhesive layer thereof
PT615754E (pt)	2002-11-29	Formas solidas de administracao oral de libertacao controlada flupertina
EA199600029A3 (ru)	1997-03-31	Оральная композиция, содержащая s (+)-этодолак, способ её получения
EP0177342A3 (fr)	1987-12-02	Formulations orales de protéines thérapeutiques
SE8600496D0 (sv)	1986-02-04	Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
IL92797A0 (en)	1990-09-17	Therapeutical active substituted benzimidazole and process for its preparation
SE8701479D0 (sv)	1987-04-09	Metod for inneslutning av biologiskt verksamma preparat samt anvendning derav
AU1950388A (en)	1989-01-19	Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
AU2807689A (en)	1989-03-01	Method for the treatment of body tissues and the administration of drugs thereto
NO993841L (no)	1999-10-08	Blandinger og anordninger for redusering av virkningene av inflammasjon
ATE183639T1 (de)	1999-09-15	Zusammensetzung zur verwendung in der transdermalen verabreichung
EP0236002A3 (en)	1988-01-20	Pharmaceutical composition comprising a medicament and a water-swellable polymer
NZ229023A (en)	1990-09-26	1,1-dioxo-cephem-4-carbothiolic acid derivatives, pharmaceutical compositions and methods of preparation
NO169835C (no)	1992-08-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive katecholkarboksylderivater
EP0403530A4 (en)	1991-09-11	Storage-stable compositions and methods for treating keratinous tissue
EP0351876A3 (fr)	1990-04-18	Composition pour augmenter l'effet de vaccination
NO172491C (no)	1993-07-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
HK8994A (en)	1994-02-04	Medicament for treatment of pregnancy-induced hypertension
HUT49590A (en)	1989-10-30	Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same as active ingredient
AU4847390A (en)	1990-08-13	Fluorinated flavone acetic acid
EP0367509A3 (fr)	1991-05-15	Formulations